Epia Neuro launches with BCI implant for post-stroke recovery
firstwordhealthtech.com/story/7158572

China's StairMed secures nearly $73M as brain implant race heats up firstwordhealthtech.com/story/7159152

Trump unveils up to 100% pharmaceutical tariffs on some drugs firstwordpharma.com/story/7158829

Novo says indirect data favour its Wegovy pill over Lilly's new obesity entrant $NVO $LLY firstwordpharma.com/story/7158056

Gilead ends HIV treatment study paused by the FDA $GILD firstwordpharma.com/story/7157441

AstraZeneca touts quadruplet approach in earlier-stage liver cancer $AZN firstwordpharma.com/story/7157369

Alto suffers mid-stage blow in schizophrenia, ramps up depression drug $ANRO firstwordpharma.com/story/7157223

Immunovant's batoclimab falters in thyroid eye disease trials $ROIV firstwordpharma.com/story/7157289

Korsana takes its brain shuttle tech public via reverse merger with Cyclerion firstwordpharma.com/story/7157143

Biopharma bites: Axsome adds an asset from Takeda, IO Biotech's farewell, and Evotec's new commercial leader $AXSM $TAK $EVT $IOBT firstwordpharma.com/story/7157140

Lagging US recruitment scuttles Pfizer, BioNTech COVID-19 vaccine study: report firstwordpharma.com/story/7157141

ORIC details Phase III prostate cancer plans for PRC2 inhibitor $ORIC firstwordpharma.com/story/7157137

With an FDA nod, Lilly's oral GLP-1 enters the obesity ring as Foundayo $LLY firstwordpharma.com/story/7156789

NHS set to expand Wegovy access to over a million at high CV risk $NVO firstwordpharma.com/story/7156792

FDA pushes back Orca Bio cell therapy decision to July firstwordpharma.com/story/7156638

Enveda touts early data for AI-discovered atopic dermatitis candidate firstwordpharma.com/story/7156506

Biopharma bites: Novo sheds 400 Indiana jobs, Alltrna nears clinical milestone, and more from Astellas, Sanofi $NVO $ALPMY $SNY firstwordpharma.com/story/7156532

Boehringer doubles down on OpenProtein antibody discovery pact firstwordpharma.com/story/7156470

Boehringer doubles down on OpenProtein.AI antibody discovery pact
firstwordhealthtech.com/story/7156470

WHOOP rakes in $575M, boosting valuation over $10B
firstwordhealthtech.com/story/7156215

Novo Nordisk rolls out Wegovy subscription $NVO firstwordpharma.com/story/7156195

Amgen's Tavneos under fresh scrutiny after FDA flags liver injury deaths $AMGN firstwordpharma.com/story/7156063

Biogen scoops up Apellis for $5.6B, adding eye and kidney drugs $BIIB $APLS firstwordpharma.com/story/7155843

Merck & Co. inks $838M deal to mine human immune system for new drugs $MRK firstwordpharma.com/story/7155842

Lilly to buy Centessa and its OX2R agonist pipeline for $6.3B $LLY $CNTA firstwordpharma.com/story/7155841

AstraZeneca suffers setback in efforts to secure broad use for hypophosphatasia therapy $AZN firstwordpharma.com/story/7155840

Takeda again trims its Massachusetts headcount, with more US layoffs on the way $TAK firstwordpharma.com/story/7155448

Blackstone's sixth fund closes at record-breaking $6.3B firstwordpharma.com/story/7155163

Aurinia agrees to buy Kezar and its beleaguered hepatitis asset for $51M $AUPH $KZR firstwordpharma.com/story/7154280

Merck & Co.'s oral PCSK9 yields over 64% LDL-C drop in add-on setting $MRK #ACC2026 firstwordpharma.com/story/7154222